eF-site ID 1qmz-ABCDEF
PDB Code 1qmz
Chain A, B, C, D, E, F

click to enlarge
Title PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX
Classification CELL CYCLE
Compound CELL DIVISION PROTEIN KINASE 2
Source Homo sapiens (Human) (1QMZ)
Sequence A:  SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT
ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV
FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH
SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY
XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR
RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS
FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA
ALAHPFFQDVTKPVPHL
B:  VPDYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMRAIL
VDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQ
LVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRM
EHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKVESLAM
FLGELSLIDADPYLKYLPSVIAGAAFHLALYTVTGQSWPE
SLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKYK
NSKYHGVSLLNPPETLNL
C:  SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT
ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV
FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH
SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY
XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR
RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS
FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA
ALAHPFFQDVTKPVPHL
D:  VPDYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMRAIL
VDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQ
LVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRM
EHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKVESLAM
FLGELSLIDADPYLKYLPSVIAGAAFHLALYTVTGQSWPE
SLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKYK
NSKYHGVSLLNPPETLNL
E:  HHASPRK
F:  HHASPRK
Description (1)  CELL DIVISION PROTEIN KINASE 2 (E.C.2.7.1.-), G2/MITOTIC-SPECIFIC CYCLIN A, SUBSTRATE PEPTIDE


Functional site

1) chain A
residue 132
type
sequence N
description BINDING SITE FOR RESIDUE MG A 383
source : AC1

2) chain A
residue 145
type
sequence D
description BINDING SITE FOR RESIDUE MG A 383
source : AC1

3) chain C
residue 132
type
sequence N
description BINDING SITE FOR RESIDUE MG C 383
source : AC2

4) chain C
residue 145
type
sequence D
description BINDING SITE FOR RESIDUE MG C 383
source : AC2

5) chain A
residue 10
type
sequence I
description BINDING SITE FOR RESIDUE ATP A 381
source : AC3

6) chain A
residue 12
type
sequence E
description BINDING SITE FOR RESIDUE ATP A 381
source : AC3

7) chain A
residue 13
type
sequence G
description BINDING SITE FOR RESIDUE ATP A 381
source : AC3

8) chain A
residue 14
type
sequence T
description BINDING SITE FOR RESIDUE ATP A 381
source : AC3

9) chain A
residue 31
type
sequence A
description BINDING SITE FOR RESIDUE ATP A 381
source : AC3

10) chain A
residue 33
type
sequence K
description BINDING SITE FOR RESIDUE ATP A 381
source : AC3

11) chain A
residue 81
type
sequence E
description BINDING SITE FOR RESIDUE ATP A 381
source : AC3

12) chain A
residue 82
type
sequence F
description BINDING SITE FOR RESIDUE ATP A 381
source : AC3

13) chain A
residue 83
type
sequence L
description BINDING SITE FOR RESIDUE ATP A 381
source : AC3

14) chain A
residue 86
type
sequence D
description BINDING SITE FOR RESIDUE ATP A 381
source : AC3

15) chain A
residue 89
type
sequence K
description BINDING SITE FOR RESIDUE ATP A 381
source : AC3

16) chain A
residue 129
type
sequence K
description BINDING SITE FOR RESIDUE ATP A 381
source : AC3

17) chain A
residue 131
type
sequence Q
description BINDING SITE FOR RESIDUE ATP A 381
source : AC3

18) chain A
residue 132
type
sequence N
description BINDING SITE FOR RESIDUE ATP A 381
source : AC3

19) chain A
residue 134
type
sequence L
description BINDING SITE FOR RESIDUE ATP A 381
source : AC3

20) chain A
residue 145
type
sequence D
description BINDING SITE FOR RESIDUE ATP A 381
source : AC3

21) chain E
residue 5
type
sequence S
description BINDING SITE FOR RESIDUE ATP A 381
source : AC3

22) chain C
residue 10
type
sequence I
description BINDING SITE FOR RESIDUE ATP C 381
source : AC4

23) chain C
residue 12
type
sequence E
description BINDING SITE FOR RESIDUE ATP C 381
source : AC4

24) chain C
residue 13
type
sequence G
description BINDING SITE FOR RESIDUE ATP C 381
source : AC4

25) chain C
residue 14
type
sequence T
description BINDING SITE FOR RESIDUE ATP C 381
source : AC4

26) chain C
residue 18
type
sequence V
description BINDING SITE FOR RESIDUE ATP C 381
source : AC4

27) chain C
residue 31
type
sequence A
description BINDING SITE FOR RESIDUE ATP C 381
source : AC4

28) chain C
residue 33
type
sequence K
description BINDING SITE FOR RESIDUE ATP C 381
source : AC4

29) chain C
residue 81
type
sequence E
description BINDING SITE FOR RESIDUE ATP C 381
source : AC4

30) chain C
residue 83
type
sequence L
description BINDING SITE FOR RESIDUE ATP C 381
source : AC4

31) chain C
residue 86
type
sequence D
description BINDING SITE FOR RESIDUE ATP C 381
source : AC4

32) chain C
residue 89
type
sequence K
description BINDING SITE FOR RESIDUE ATP C 381
source : AC4

33) chain C
residue 129
type
sequence K
description BINDING SITE FOR RESIDUE ATP C 381
source : AC4

34) chain C
residue 131
type
sequence Q
description BINDING SITE FOR RESIDUE ATP C 381
source : AC4

35) chain C
residue 132
type
sequence N
description BINDING SITE FOR RESIDUE ATP C 381
source : AC4

36) chain C
residue 134
type
sequence L
description BINDING SITE FOR RESIDUE ATP C 381
source : AC4

37) chain C
residue 145
type
sequence D
description BINDING SITE FOR RESIDUE ATP C 381
source : AC4

38) chain F
residue 5
type
sequence S
description BINDING SITE FOR RESIDUE ATP C 381
source : AC4

39) chain A
residue 19
type MOD_RES
sequence Y
description Phosphotyrosine => ECO:0007744|PubMed:19369195
source Swiss-Prot : SWS_FT_FI9

40) chain C
residue 19
type MOD_RES
sequence Y
description Phosphotyrosine => ECO:0007744|PubMed:19369195
source Swiss-Prot : SWS_FT_FI9

41) chain A
residue 127
type ACT_SITE
sequence D
description Proton acceptor
source Swiss-Prot : SWS_FT_FI1

42) chain C
residue 127
type ACT_SITE
sequence D
description Proton acceptor
source Swiss-Prot : SWS_FT_FI1

43) chain A
residue 10
type BINDING
sequence I
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702
source Swiss-Prot : SWS_FT_FI2

44) chain C
residue 129
type BINDING
sequence K
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702
source Swiss-Prot : SWS_FT_FI2

45) chain A
residue 33
type BINDING
sequence K
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702
source Swiss-Prot : SWS_FT_FI2

46) chain A
residue 81
type BINDING
sequence E
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702
source Swiss-Prot : SWS_FT_FI2

47) chain A
residue 86
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702
source Swiss-Prot : SWS_FT_FI2

48) chain A
residue 129
type BINDING
sequence K
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702
source Swiss-Prot : SWS_FT_FI2

49) chain C
residue 10
type BINDING
sequence I
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702
source Swiss-Prot : SWS_FT_FI2

50) chain C
residue 33
type BINDING
sequence K
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702
source Swiss-Prot : SWS_FT_FI2

51) chain C
residue 81
type BINDING
sequence E
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702
source Swiss-Prot : SWS_FT_FI2

52) chain C
residue 86
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702
source Swiss-Prot : SWS_FT_FI2

53) chain A
residue 160
type MOD_RES
sequence X
description Phosphothreonine; by CAK and CCRK => ECO:0000269|PubMed:1396589, ECO:0000269|PubMed:14597612, ECO:0000269|PubMed:16325401, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:17570665, ECO:0000269|PubMed:20147522, ECO:0000269|PubMed:20360007, ECO:0000269|PubMed:21565702, ECO:0000305|PubMed:28666995
source Swiss-Prot : SWS_FT_FI10

54) chain C
residue 160
type MOD_RES
sequence X
description Phosphothreonine; by CAK and CCRK => ECO:0000269|PubMed:1396589, ECO:0000269|PubMed:14597612, ECO:0000269|PubMed:16325401, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:17570665, ECO:0000269|PubMed:20147522, ECO:0000269|PubMed:20360007, ECO:0000269|PubMed:21565702, ECO:0000305|PubMed:28666995
source Swiss-Prot : SWS_FT_FI10

55) chain A
residue 132
type BINDING
sequence N
description BINDING => ECO:0000269|PubMed:21565702
source Swiss-Prot : SWS_FT_FI3

56) chain A
residue 145
type BINDING
sequence D
description BINDING => ECO:0000269|PubMed:21565702
source Swiss-Prot : SWS_FT_FI3

57) chain C
residue 132
type BINDING
sequence N
description BINDING => ECO:0000269|PubMed:21565702
source Swiss-Prot : SWS_FT_FI3

58) chain C
residue 145
type BINDING
sequence D
description BINDING => ECO:0000269|PubMed:21565702
source Swiss-Prot : SWS_FT_FI3

59) chain A
residue 1
type MOD_RES
sequence M
description N-acetylmethionine => ECO:0007744|PubMed:22814378
source Swiss-Prot : SWS_FT_FI5

60) chain C
residue 1
type MOD_RES
sequence M
description N-acetylmethionine => ECO:0007744|PubMed:22814378
source Swiss-Prot : SWS_FT_FI5

61) chain A
residue 14
type MOD_RES
sequence T
description Phosphothreonine => ECO:0000269|PubMed:1396589, ECO:0000269|PubMed:17095507
source Swiss-Prot : SWS_FT_FI7

62) chain C
residue 14
type MOD_RES
sequence T
description Phosphothreonine => ECO:0000269|PubMed:1396589, ECO:0000269|PubMed:17095507
source Swiss-Prot : SWS_FT_FI7

63) chain B
residue 211-242
type prosite
sequence RAILVDWLVEVGEEYKLQNETLHLAVNYIDRF
description CYCLINS Cyclins signature. RaiLvdWLvevgeeykLqnetLhlAVnYIDRF
source prosite : PS00292

64) chain A
residue 10-33
type prosite
sequence IGEGTYGVVYKARNKLTGEVVALK
description PROTEIN_KINASE_ATP Protein kinases ATP-binding region signature. IGEGTYGVVYkArnkltgev..........VALK
source prosite : PS00107

65) chain A
residue 123-135
type prosite
sequence VLHRDLKPQNLLI
description PROTEIN_KINASE_ST Serine/Threonine protein kinases active-site signature. VlHrDLKpqNLLI
source prosite : PS00108

66) chain A
residue 9
type SITE
sequence K
description CDK7 binding
source Swiss-Prot : SWS_FT_FI4

67) chain A
residue 88
type SITE
sequence K
description CDK7 binding
source Swiss-Prot : SWS_FT_FI4

68) chain A
residue 166
type SITE
sequence L
description CDK7 binding
source Swiss-Prot : SWS_FT_FI4

69) chain C
residue 9
type SITE
sequence K
description CDK7 binding
source Swiss-Prot : SWS_FT_FI4

70) chain C
residue 88
type SITE
sequence K
description CDK7 binding
source Swiss-Prot : SWS_FT_FI4

71) chain C
residue 166
type SITE
sequence L
description CDK7 binding
source Swiss-Prot : SWS_FT_FI4

72) chain A
residue 6
type MOD_RES
sequence K
description N6-acetyllysine => ECO:0007744|PubMed:19608861
source Swiss-Prot : SWS_FT_FI6

73) chain C
residue 6
type MOD_RES
sequence K
description N6-acetyllysine => ECO:0007744|PubMed:19608861
source Swiss-Prot : SWS_FT_FI6

74) chain A
residue 15
type MOD_RES
sequence Y
description Phosphotyrosine; by WEE1 => ECO:0000269|PubMed:1396589, ECO:0000269|PubMed:17095507, ECO:0007744|PubMed:19690332
source Swiss-Prot : SWS_FT_FI8

75) chain C
residue 15
type MOD_RES
sequence Y
description Phosphotyrosine; by WEE1 => ECO:0000269|PubMed:1396589, ECO:0000269|PubMed:17095507, ECO:0007744|PubMed:19690332
source Swiss-Prot : SWS_FT_FI8


Display surface

Download
Links